Hand hygiene (HH) is the single most important factor in the prevention of health care-acquired infections. The 3 most frequently reported methods of measuring HH compliance are: (1) direct observation, (2) self-reporting by health care workers (HCWs), and (3) indirect calculation based on HH product usage. This article presents the results of a 12-month multicenter collaboration assessing HH compliance rates at US health care facilities by measuring product usage and providing feedback about HH compliance. Our results show that HH compliance at baseline was 26% for intensive care units (ICUs) and 36% for non-ICUs. After 12 months of measuring product usage and providing feedback, compliance increased to 37% for ICUs and 51% for non-ICUs. (ICU, P = .0119; non-ICU, P < .001). HH compliance in the United States can increase when monitoring is combined with feedback. However, HH still occurs at or below 50% compliance for both ICUs and non-ICUs. (Am J Med Qual 2009;24:205-213)
The importance of hand hygiene (HH) in the control of infection has been recognized since the initial reports of Semmelweis in 1847. 1 Several studies have shown a decrease in transmission of infection as HH increases. [2] [3] [4] [5] [6] [7] In 2002, the "Guidelines for Hand Hygiene in Health Care Facilities," 8 and in 2005, the "World Health Organization (WHO) Guidelines on Hand Hygiene in Health Care," 9 presented current knowledge about hygiene products, clinical relevance, and evaluation of effective systems to promote and monitor HH compliance. However, measuring the impact of educational interventions that promote increased HH was not fully addressed by health care facilities until the Joint Commission released National Patient Safety Goal 7A (2005), 10 which recommends monitoring HH compliance.
Although the Centers for Disease Control and Prevention, WHO, Joint Commission, and Institute for Healthcare Improvement (IHI) all recognize the importance of monitoring HH compliance, there is no standard for measuring it. In 2007, Haas et al conducted an extensive review of the literature on HH monitoring, resulting in 662 articles of which only 31 described the method used to measure HH compliance. 11 The reviewers identified the 3 most frequently reported methods of measuring compliance as: (1) direct observation, (2) self-reporting by health care worker (HCW), and (3) indirect calculations based on HH product usage.
This article presents the methodology and results of a 1-year collaborative study of the indirect determination of HH compliance by measurement of product usage volume and the effect of feedback reporting on compliance. The role of measurement within a health care facility's overall program of improving HH using observation, education, and reporting is discussed.
METHODS

Site Enrollment
The measurement program was offered to all health care facilities in the United States. The only criteria for enrollment was the ability and willingness of sites to submit monthly summaries of product usage volume and patient bed days to a secure protected database for use in generating measuring and benchmarking reports. Sites were encouraged to use the reports to provide feedback to their HCWs. Each site received an implementation manual and support from the authors to implement the program at their facility.
Product Usage Monitoring
Soap and sanitizer usage was monitored by collecting and counting empty (used) product containers and keeping the sum of soap containers separate from that of sanitizer containers. The sum of empty containers was either provided by a health care facility's environmental services or gathered by internally assigned staff who would monitor and count empty containers. The tallies of empty soap and sanitizer containers were recorded either separately by each unit (ie, a specific floor or department within the facility), or tallies for all units were combined and reported as 1 facility-wide effort.
Patient Bed Days or Patient Visits
In conjunction with monitoring product usage volume, the study required infection control practitioners (ICPs) to record and submit patient bed-day data for each unit monitored for the study. In the case of emergency rooms (ERs) or other outpatient units, such as clinics, the number of patient visits substituted for patient bed days. As with product usage, if a facility decided to combine all units into 1 facility-wide monitoring effort, then patient bed days and patient visits were also combined into 1 facilitywide number and submitted.
Data Collection Timetable
Product usage was monitored and reported starting at a baseline (period numbered as 0) and then monthly thereafter (eg, periods numbered 1, 2, 3). The baseline served as the starting point to which all future months' data would be compared. For each monthly period, environmental services or staff monitors reported the total number of empty soap, empty sanitizer, and patient bed days for each unit they monitored. Then, the count started over for each subsequent month. Most data were collected by on-site staff and submitted to the authors by a single representative from that facility, usually the ICP. Data were submitted electronically, faxed, or mailed by the 15th of each month and reports were generated and sent via e-mail (as a PDF) to each enrolled site by the 22nd of each month. Facilities that submitted data for individual units received reports for each unit. Facilities that submitted their data as a facilitywide sum for product usage and bed days received 1 report for the entire facility.
Data Analysis
HH per patient bed day. HH/patient bed day was calculated in a multistep process, starting with multiplying the number of used containers of soap or sanitizer by the number of milliliters for each respective product container size. Ounces were converted to milliliters if required for this step. The resulting number was the total product volume (in milliliters) used for that monthly period. That total product volume was divided by the number of patient bed days, resulting in a number that represented the total volume of product used per patient per day (also in milliliters). Finally, that total product per patient per day was divided by 1.7 mL (because industry literature suggests that 1.7 mL is the average volume of a single dose of product from a sink or freestanding product dispenser). This final number represents the HH/patient bed day. For ER and other outpatient units, the number represents HH/patient visit. This represents either the number of times HH occurred in a 24-hour period when there was a patient in a bed or, for outpatient units, the number of times HH occurred per patient visit.
Statistical methods. To test the statistical significance of the intervention, paired t tests were performed on the log-transformed HH per patient bed day data for the different unit types.
Benchmarks. The benchmarks are calculated using data from every unit of every health care facility that participated in the program. The methodology used for benchmarking was a linear regression model and the percentile benchmarks are drawn from the same model using prediction intervals.
Comparative benchmark. Benchmarks are drawn at the expected mean over all comparable units and at the 10th and 90th percentiles. The comparisons are made against similar unit types and by hospital size classifications according to their licensed number of beds. Benchmarks are not calculated by the number of staff contacts with the patient or by the category of staff because these factors are determined by the type of unit.
There are 6 unit types: (1) intensive care unit (ICU); (2) non-ICU; (3) rehab/long-term care (rehab/ LTC); (4) pediatric; (5) ER outpatient units (ER-OP); and (6) clinic.
There are 4 size classifications according to the number of licensed beds: (1) 1 to 100 beds, (2) 101 to 300 beds, (3) 301 to 500 beds, and (4) 500 or more beds. This cross-classification generates 24 different possible reference groups that can be benchmarked.
For this report, benchmarks are presented for the ICU and non-ICU categories. Data on the remaining unit types will include the number of units and the baseline mean because there are not sufficient data points at this time to benchmark.
Compliance goals. Table 1 lists the HH goals and evidence that was used to determine compliance goals for the 6 unit types. There are no compliance goals for a health care facility that reports a combined unit summary of product usage. Four types of research were used to determine these goals: (4) ongoing monitoring of the database used in this study. Any type of HH action that involves soap or sanitizer counts as an occurrence for HH compliance.
When an individual unit receives their HH/ patient bed day, that number is then compared to the compliance goal. A percentage or compliance rate is determined that puts the unit's HH/patient bed day in perspective with their goal.
Measurement Reports
After an ICP submits data on soap and sanitizer product usage to our database, a report is generated that contains 4 graphs and 1 table that are used to visually display that month's HH/patient bed day and the compliance rate. These reports are used for feedback to HCWs and to provide the ICP with a form of intervention. The graphs show how that particular unit is benchmarked with other units within that facility's size classification.
The 4 graphs and 1 table are explained as follows:
1. HH/patient bed day line graph for soap in the unit, for the entire time period the unit has been reporting data. Each monthly intervention is represented by a point on the line graph, allowing easy review of increases or decreases in HH/patient bed day over a period of several monthly interventions.
2. HH/patient bed day (or HH/patient visit) line graph for sanitizer in the unit, for the entire time period the unit has been reporting data. This is similar to the line graph for soap.
3. HH/patient bed day (or HH/patient visit for ER-OPs) line graph for combined soap and sanitizer in the unit, for the entire time period the unit has been reporting data. The individual HH/patient bed day for soap and sanitizer are combined into 1 number per intervention period, so that 1 line graph displays the comprehensive HH product use for that unit. This graph shows the compliance goal for that unit type.
4. HH/patient bed day bar graph for soap, sanitizer, and combined soap and sanitizer. These are the same data results as presented in each line graph described, but soap and sanitizer usage is represented by vertical bars instead of as points on a time line.
5. HH/patient bed day for soap, sanitizer, and combined soap and sanitizer, with compliance rate. This table documents the HH/patient bed day for each intervention period and shows individual soap and sanitizer product use, combined product use, and the compliance rate when the combined use is compared to the goal for the unit type.
RESULTS
The time period chosen for performing the statistical analysis of the intervention was 12 months because this represented a good compromise between having a sufficient sample size to obtain reasonable statistical power for the test and having enough time elapsed from baseline to judge the medium-term effectiveness of the program. Figure 1 shows the geographic distribution of the database used for this analysis. Health care facilities are shown by state and facility size classification. The database comprises urban and rural facilities from across the United States. It also has facilities represented in each size category.
In this study, a total of 306 hospitals and other health care facilities submitted data for a total of 1531 units: 179 hospitals reported product use for 299 ICUs, and 281 hospitals reported product use for 986 non-ICUs. There were a combined number of 246 data points for pediatrics, rehab/LTC, and ER-OP. Table 2 shows the mean HH/patient bed day over the period of 12 months for all ICUs and non-ICUs, as well as their respective compliance rates. The compliance rate for ICUs at period 0, the baseline, was 25.8% and increased to 36.3% by period 12 (the 1-year intervention mark, P = .0119). For non-ICUs, the baseline was 35.7% and increased to 51.3% by period 12 (P < .0001). There is not sufficient data to perform a formal test of significance for the pediatrics, rehab/LTC, clinic, and ER-OP unit types. However, Table 3 shows the mean baseline of the limited data points we have for the HH/patient bed day for rehab/LTC and pediatrics to be 17.2 and 31.2, respectively. ER-OP is 9.3 HH/patient visit and clinic is 3.7 HH/patient visit. Based on our established compliance goals, rehab/LTC has a mean compliance rate of 88%, and the rate for pediatrics is 43%. Table 4 shows the percentage change in compliance for sites enrolled in the program for 12 months (21 ICUs and 88 non-ICUs). The median percentage change for ICUs from baseline to 12 months was 63%, whereas the median percentage change for non-ICUs was 92%. Figure 2 shows aggregate HH/patient bed day for all 299 ICUs' combined soap and sanitizer usage. The mean HH/patient bed day for each intervention period is indicated by squares. Benchmarks are shown at the 10th percentile (bottom 10%, indicated by triangles) and the 90th percentile (top 10%, indicated by diamonds). The goal for ICUs, 144 HH/ patient bed day, is indicated by the horizontal dashed line. We include an actual hospital's data from our database as an example of how monthly tracking would look in an actual report that is sent to an ICP. This hospital's HH/patient bed day are indicated by circles connected by the thick black line. Figure 3 shows the aggregate HH/patient bed day for all non-ICUs' combined soap and sanitizer usage. Our database has a total of 986 non-ICUs. The mean HH/patient bed day for each intervention period is indicated by squares. Benchmarks are shown at the 10th percentile (bottom 10%, indicated by triangles) and the 90th percentile (top 10%, indicated by diamonds). The goal for non-ICUs, 72 HH/patient bed day, is indicated by the horizontal dashed line. We include an actual hospital's data from our database as an example of how monthly tracking would look in an actual report that is sent to an ICP. This hospital's HH/patient bed day are indicated by circles connected by the thick black line. 
DISCUSSION
Numerous studies over the last 25 years have documented the lack of HH compliance among HCWs. These studies have been hospital-specific or unit-specific and the majority has used either observation or HCW self-report of the measurements. To our knowledge, this study is the first multi-center project in the United States designed to measure and benchmark HH compliance indirectly by using the measurement of product volume and cross-classification that generated 24 reference groups for benchmarking.
Direct observation is recognized by WHO 9 as the gold standard and most reliable method for measuring HH compliance rates. Although direct observation can provide specific information about HH techniques and HCW HH behavior, it is costly and labor intensive. Table 5 compares labor costs for observation versus product usage measurement. Costs for ICP time and salary to manage and supervise an observational study can range from 2.5 to 3.5 times higher than costs for an ICP to manage a monitoring program for product usage.
The lack of a standardized process for observation along with bias selection and small sampling has made data hard to interpret or compare. Gould et al identified 42 techniques for measuring hand washing performance using direct observation. 18 They found poorly derived studies, a limited scope in terms of time and type of units, and that validity and reliability were not addressed. The authors concluded that an additional data collection method should be used to address the deficiencies of observation. The most significant deficiency in a. Baseline (period 0) mean for rehabilitation/long-term care and pediatric (reported as HH/per patient bed day), and mean for emergency room, outpatient clinics (such as a vascular lab), and clinics (such as dermatology) reported as HH/per patient visit. observation is the small sampling size. The most comprehensive study of this issue was done by van de Mortel et al, who reported that covert observation captures only 3% of encounters. 19 Indirect measurements of HH (eg, product volume, paper towels, containers of touch-free dispensers) have reported good correlation with infection rates and resistant organisms, and increased compliance. [20] [21] [22] [23] [24] [25] Product usage is a costeffective, less time-consuming method that provides the ICP with an overall compliance rate for each unit, representative of all shifts, and avoids the biases of selection and self-reporting.
The methodology for product usage measurement does not produce data for HH techniques, nor does it provide indications in terms of before and after patient contact. For these reasons, product usage measurement can be a cost-effective way to determine which units should be observed to better understand noncompliance HH behaviors for a specific unit.
Research studies have shown that a sound component of a compliance program is reporting and feedback. Rosenthal et al 26 reported a significant increase in HH compliance when performance feedback was introduced. Similar results were reported by McCormick et al 27 on the use of unitspecific report cards. The discussion (and promotion) of HH goals and the unit's compliance toward those goals provided motivation to increase HH. The measurement and benchmarking reports, whose data are impacted by the educational efforts of a facility's HH awareness, were used to influence that educational program. The reports were used in monthly infection control committee meetings, unit staff meetings, and training sessions, to provide feedback for that unit's HH behavior.
Standardization of HH measurement should be the foundation of a compliance program and the process of applying a standard methodology will increase the probability of improving HH compliance. The HH compliance measurement process employed in our multicenter program uses a standard methodology for all units at all facilities and provides a standard reporting method that can be used for feedback and benchmarking. It provides a method for monitoring and unit-specific feedback, both of which have been shown to increase and sustain HH compliance. [21] [22] [23] [24] [25] The compliance rates from this study represent the first attempt to look at monitoring across the United States using a standard collection method, data analysis, and benchmarking based on compliance goals. These results are the first to differentiate between ICUs and non-ICUs, and the first to quantify compliance for both types of units.
The aggregate results show that the mean HH/ patient bed day in the ICU at the onset of monitoring was 37, meaning that HH occurred on average 37 times in a 24-hour period when there was a patient in the bed. Based on our established goals, there should be approximately 144 HH in a 24-hour period when there is a patient in an ICU bed. Therefore, the compliance rate for ICUs is 25%. At 12 months, HH/patient bed day increased to 52 HH/patient bed day, which is a compliance rate of 36%.
The mean HH/patient bed day for non-ICUs was 26. The established goal is 72 HH/patient bed day (a 36% compliance rate). At 12 months, non-ICUs increased to 37 HH/patient bed day, a 51% compliance rate. Our data have also shown that pediatrics has a higher mean compliance rate than ICU and non-ICU, a fact that has been shown in previous studies on HH in pediatrics. 17, [28] [29] There was a median change in compliance of 63.9% for ICUs and 92% for non-ICUs for sites enrolled for a year.
National multicenter studies on HH have been performed in southern Mediterranean countries and in Turkey. In a national multicenter study in Turkey, Arikan Akan et al 30 reported similarly low compliance rates of 29.8% HH for ICUs. Amazian et al 31 reported HH compliance rates in 4 southern Mediterranean countries as part of the NosoMed Network. They found similarly low compliance rates of 27.6% overall, with lack of consumables a significant factor.
The limitations of this study are related to product monitoring and compliance goals. Although we have standardized the process for collecting and submitting product volume (collecting the empty containers), it still remains a manual process and therefore human error can occur. The effect of human error on a specific site is not critical because each site is monitored and compared to their baseline data. Consistency is the key even if there are a few minor flaws. We have found that the process of establishing a baseline and first month's intervention requires each site to begin each of these periods by replacing all soap and sanitizer containers in each unit of their study, so that product use can be measured more precisely. If there is a significant error in measurement in the months following the baseline and first month, it is more obvious when compared to the earlier interventions and we can help that facility's ICP identify where the error in measurement occurred. Our compliance goals were based on published articles that described a total of several thousand observation hours. The goals also are based on ongoing observation as sites participated in this study. Our goals may be too low due to the reported lack of standardization of observation and the reported low yield using this process. We believe this is the case for the rehab/LTC, ER-OP, and clinic goals we have noted due to the variability in defining these units and the difference in the acuity of patients. However, even with possible low goals, compliance for ICUs and non-ICUs is still near or below 50% in this multicenter study.
Our findings have documented 3 important facts: (1) monitoring and feedback can result in a modest but statistically significant increase in HH compliance; (2) HH in the United States continues to be near or below 50%, with compliance slightly higher for non-ICUs than for ICUs; and (3) monitoring compliance through product volume is a time-efficient, cost-effective way to provide feedback to staff and provide direction for observation and education.
